• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Education
  • Events
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs
  • Business Directory

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

Scottish pharmacies to get emergency care summary access

18th March 2020 by PIP editor Leave a Comment

 

In a letter published yesterday, the Scottish Government have agreed to give community pharmacies access to the emergency care summary as part of the response to the COVID-19 outbreak.

 

In the letter, Chief Pharmaceutical Officer Rose Marie Parr, Deputy Director, Digital Health and Care Jonathan Cameron and Deputy Director, Primary Care Aidan Grisewood said the following:

 

“The Scottish Government has been preparing to issue Directions regulating access to the data processed by the Emergency Care Summary (“ECS”) system. It is intended that those Directions will supersede the existing Chief Medical Officer and Chief Dental Officer letters on the subject.

 

“The intention is that the Directions will also include pharmacists and pharmacy technicians working in Community Pharmacy amongst the staff groups to whom access could be granted for the purposes of providing health care.

 

“These Directions are in the process of being prepared and will be issued in due course. However, in light of the outbreak of Covid-19 in Scotland, we are now informing Health Boards that they may provide access to the ECS data set to pharmacists and pharmacy technicians as part of their Covid-19 response, providing that it is practical to do so and Health Boards are satisfied that they can appropriately discharge their data protection obligations.

 

“This measure will assist in increasing the ability of community pharmacists to manage patients in the community at a time of unprecedented demand for health services.

 

“This measure is supported by the Scottish General Practitioners’ Committee of the BMA. The intention is that Directions regulating access to the ECS system will be issued in due course.

 

“The Information Commissioner’s Office has issued guidance relating to data protection and the Covid-19 outbreak which health organisations should be aware of can be accessed by clicking here.”

 

Jonathan Burton, Chair of RPS Scotland, said:

 

“RPS has been campaigning for a long time to get access to patient records for all pharmacists. Today’s announcement is a very welcome first step and is a positive move forward for patient care in these unprecedented times.

 

“Pharmacists and their teams are working flat out to support the public and the NHS. We want to ensure the government continues to support the vital role that pharmacy teams have in caring for their local communities. Yesterday we published 6 essential asks that we believe are vital to enabling pharmacy to cope with the workload they are facing.

 

“Pharmacy teams are often the first place the public go for health care and we are seeing a significant increase in the number of people attending their local pharmacy.  It’s vital that staff should feel safe to continue looking after patients. We are calling for Personal Protective Equipment (PPE) to be made available to those pharmacy teams who need it. Frontline staff, including pharmacists and their staff, must be protected, and testing them for the virus should also be a priority.

 

“We expect to see an increased impact on pharmacy services, which are already under pressure. Pharmacists in both secondary and primary care settings are key to supporting medicines safety and providing frontline services to patients. It is essential that all pharmacists supporting the health service are given access to health and wellbeing support at this crucial time.”

 

You can read the full letter by clicking here.

 

 

This circular is being shared under the Open Government Copyright licence.

 

 

Share this:

  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Related

Next article  Covid-19 community pharmacy vaccine campaign begins

Filed Under: News Tagged With: Coronavirus, PIP news

Register for our upcoming webinar and live Q&A

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Categories

Follow Us

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter

PIP business directory

Letters to the editor

Letters to the editor

Pharmacists must leave their comfort zone for the sector to thrive

Resitters: The forgotten pre-registration pharmacist cohort

People can easily go to multiple pharmacies to buy codeine

Pharmacists should not have to bend the rules

More letters to the editor here...

Blogs

💊 PIP live pharmacy blog

Winter stresses must not ‘destabilise’ general practice

What is it like to depend on medicine to treat endometriosis?

Opinion

Why is pharmacy not integral to government mass vaccination plans?

Pharmacy Covid-19 vaccination involvement is a ‘no-brainer’

The great patient medication returns debacle

CPD Challenges

💊 CPD Challenge: How well do you understand pulmonary embolisms?

💊 CPD Challenge: Prescribing and dispensing clozapine

💊 CPD Challenge: Oral anticoagulants – Dabigatran

More CPD challenges here...

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.